Description:

GOG-0241 Pathology Form (F) Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D17F7CB-70DF-90BC-E040-BB89AD435566

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D17F7CB-70DF-90BC-E040-BB89AD435566
Keywords:
  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Fallopian Tube Cancer NCT01081262 Pathology - GOG-0241 Pathology Form (F) - 3126918v1.0

No Instruction available.

  1. StudyEvent: GOG-0241 Pathology Form (F)
    1. No Instruction available.
Header Module
Primary Disease Assessment
Primary Site
Method of evaluation
Histologic Type (check one)
Histologic grade (Differentiation)
Specimen Site
Secondary Disease Assessment
Method of evaluation
Disease Status
Specimen Site

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial